CRH

DRUG4 trials

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Nottingham, Universitaire Ziekenhuizen KU Leuven, Prof Dr Jan Tack

Conditions

Esophageal Motility DisordersHealthySensitivity (Hyper); GastrointestinalSmith-Lemli-Opitz Syndrome

Phase 4

Imaging the Effect of Experimental Stress on Small and Large Bowel Water During Fructose Absorption

CompletedNCT01763281

University of NottinghamHealthy

Start: 2012-10-31End: 2013-02-28Updated: 2013-02-06

The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Sensitivity in Healthy Volunteers

CompletedNCT02674256

Universitaire Ziekenhuizen KU LeuvenSensitivity (Hyper); Gastrointestinal

Start: 2014-03-31End: 2014-05-31Updated: 2016-02-04

The Effect of Corticotrophin-releasing Hormone (CRH) on Esophageal Motility in Healthy Volunteers

CompletedNCT02736734

Prof Dr Jan TackEsophageal Motility Disorders

Start: 2014-10-31End: 2014-12-31Updated: 2016-04-13

Unknown Phase

Study of Smith-Lemli-Opitz Syndrome

CompletedNCT00001721

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Smith-Lemli-Opitz Syndrome

Start: 1998-09-13Updated: 2026-09-16

Related Papers

Assessing Postnatal Mortality in Smith–Lemli–Opitz Syndrome

American Journal of Medical Genetics Part A2024-09-132 citations

Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.

2023-01-3117 citations

Corticotropin-releasing factor increases ascending colon volume after a fructose test meal in healthy humans: a randomized controlled trial.

2016-04-2011 citations

Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update

Journal of Neurodevelopmental Disorders2016-04-0568 citations